ISAP ...
11th ISAP Pharmacokinetics / Pharmacodynamics (PK / PD) Educational Workshop
Washington, DC, Friday October 29th, 2004

An official workshop ot the 43d Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)

Scientific organizers: Johan W. Mouton, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands & H. Derendorf, University of Florida, Gainesville, Fla.

Vertical constellation from Calder ...
Vertical constellation from Calder ...
Part 1:
Preclinical Pharmacokinetics and Pharmacodynamics of Anti-infective Agents
8:30 am - 12 noon
Part 2:
Clinical Relevance of Pharmacokinetics and Pharmacodynamics of Anti-infective Agents
Part 3:
PK/PD Modeling of Anti-infective Agents
1:00 pm-4:30 pm



Goals and Format

Pharmacokinetics and Pharmacodynamics (PK/PD) have now become essential tools for determining the appropriate use of currently available anti-infective agents as well as for accelerating the development of new drugs.  While this is now more and more recognized by Academia, Industry and Regulatory Agencies (see the ISAP / FDA and ISAP / EMEA workshops held in 1999), there is still a lack of training into these disciplines.  Accordingly, ISAP has endeavoured to launch educational activities in this context.  The aim is to train people professionally involved in development or in the use of antiinfective drugs in the basic and applied aspects of pharmacokinetics and pharmacodynamics, showing how these sciences have emerged over the last 10 years and how their influence has grown.

Since 1999, ISAP has already organized several educational workshops in association with ECCMID and ICAAC [see "Past Educational Activities"].  Following specific demands, the educational workshop held with ICAAC since this year have been organized in three parts (half a day each) dealing with

  1. preclinical aspects
  2. analysis of the clinical relevance of PK/PD
  3. PK/PD modeling
Each part can be followed independently, but parts 1 and 2, or 1 and 3 can also be combined.


Part 1:  Preclinical Pharmacokinetics and Pharmacodynamics of Anti-infective Agents

Conveners:  Johan W. Mouton, MD, PhD (Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands) & Hartmut Derendorf, PhD (Univ. of Florida, Gainesville, FL.)

Objectives:

Intended Audience: Medical microbiologists, infectious diseases specialists, pharmacologists, and others interested

Level: Beginning

Prerequisites: None

Preclinical Pharmacokinetics and Pharmacodynamics of Anti-infective Agents

Introduction to PK/PD H. Derendorf, PhD
Department of Pharmaceutics, University of Florida, Gainsville, FL

PK/PD indices J. Mouton, MD, PhD
Canisius Wilhelmina Hospital, Nijmegen, The Netherlands

Protein binding, tissue distribution U. Theuretzbacher
Antibiotic Center, University of Vienna, Vienna, Austria

In vitro models  I. Odenholt, MD
Departement of Infectious Diseases, Malmö University Hospital, Malmö, Sweden

Animal models  W.A. Craig,
Division of Infectious Diseases, University of Wisconsin, Madison, WI

In vitro resistance O. Cars,
Division of Infectious Diseases, University Hospital, Uppsala, Sweden



Part 2: Clinical Relevance of Pharmacokinetics and Pharmacodynamics of Anti-infective Agents

Convener: Johan W. Mouton, MD, PhD; Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands.  

Objectives:
Intended Audience: Medical microbiologists, infectious diseases specialists, pharmacologists, and others interested

Level: Intermediate/Advanced
|
Prerequisites: None.

Clinical Relevance of Pharmacokinetics and Pharmacodynamics of Anti-infective Agents

Clinical applications of PK/PD Paul M. Tulkens, MD,PhD
Department of Pharmaceutics, Catholic University of Louvain, Brussels, Belgium

Drug exposure at infection site M. Mueller, MD
Department of Clinical Pharmacology, Vienna University Medical School, Vienna, Austria.

PK/PD of antivirals G.L. Drusano, MD
Division of Clinical Pharmacology, Albany Medical College, Alabany, NY

PK/PD of antifungals  D.R. Andes, MD
Department of Medicine, University of Wisconsin Medical School, Madison, WI

Clinical resistance  O. Cars, MD, MPH
Division of Infectious Diseases, University Hospital, Uppsala, Sweden

Clinical dose optimization J. Mouton, MD, PhD
Canisius Wilhelmina Hospital, Nijmegen, The Netherland



Part 3: PK/PD Modeling of Anti-infective Agents

Convener:
Hartmut Derendorf, PhD (Univ. of Florida, Gainesville, FL.)

Objectives: ·   
Intended Audience: Medical microbiologists, infectious diseases specialists, pharmacologists, and others interested

Level: Intermediate/Advanced |

Prerequisites: None.

 PK/PD Modeling of Anti-infective Agents

In vitro MIC based PK/PD A.P. MacGowan, MD,PhD
Bristol Centre for Antimicrobial Research and Evaluation, North Bristol NHS Trust & University of Bristol Department of Medical Microbiology, Southmead Hospital, Westbury-on-Trym, Bristol, UK

PK/PD in animals W.A. Craig,
Division of Infectious Diseases, University of Wisconsin, Madison, WI

PK/PD based on kill curves H. Derendorf, PhD
Department of Pharmaceutics, University of Florida, Gainsville, FL

Population PK/PD A.A. Vinks, PhD
Division of Pharmacology Research, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

Modeling of anti-infective activity A. Forrest, PhD
Clinical Pharmacokinetics Laboratory (CPL), Uiversity of New York at Buffalo, Buffalo, NY

Monte Carlo Simulations G.L. Drusano, MD
Division of Clinical Pharmacology, Albany Medical College, Alabany, NY



Continuing Education / Acreditation

This will be handled by the American Society for Microbiology (ASM).  ASM is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.  ASM has designated full-day workshops for 7 hours of category 1 credit towards the American Medical Association Physician's Recognition Award. Diplomates of the American Board of Medical Microbiology, Diplomates of the American Board of Medical Laboratory Immunology, and Registrants of the National Registry of Microbiologists may earn category 1 credit toward recertification. Each physician should claim only those hours of credit that he/she actually spent in the educational activity.



Venue

The workshop will take place in Washington, DC, at the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).  Room no. will be posted clearly at the entrance of the Convention Center.  Please, refer to the ICAAC Web site (http://www.icaac.org) site for all additional and "up to the last minute" details.



Accomodation

ISAP will not be responsible for accomodation which must be taken care of individually by each participant.  Attendants participating to the  may wish to take advantage of the offerings made by the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Please, refer to the ICAAC Web site (http://www.icaac.org) site for all additional and "up to the last minute" details. See also the "Useful links" section hereunder.



Registration

Registration is open to all ISAP members and to all professionals active or having interest in the pharmacokinetics and pharmacodynamics of antiinfective agents. 
Registration is exclusively through the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
Please, refer to the ICAAC Web site (http://www.icaac.org) site for registration. 

Important: As per ICAAC policy, attendance to workshops is limited (so as to foster interactivity and real discussions).  Registration to workshops is made by ICAAC on a first-come first-served basis.  Our experience is that these PK/PD workshops fill up pretty quickly, so that early registration is recommended.  Please, do not contact ISAP in this context. 


Useful links

p p d
ISAP
Practical and useful information on Washington and the District of Columbia
44th ICAAC

Accomodation and restaurants


Last update: February 7th, 2004




ISAPBack to ISAP home page

Credits
Back to ISAP home page